| IMUX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the IMUX shares outstanding history going back to 4/15/2019:
Also see: IMUX Market Cap History IMUX YTD Return |
IMUX Shares Outstanding History — Immunic Share Count Over Time
As of 4/30/2026 Immunic has 13.62 million IMUX shares outstanding. Investors often track the IMUX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows IMUX share count trends over time, with 31 historical shares outstanding datapoints presented, dating back to 4/15/2019.
| IMUX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IMUX Historical Shares Outstanding: +99.22% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IMUX Stock Price Chart |
| About Immunic Inc |
| Immunic, Inc. is a biotechnology company. Co. is focused on developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Co.'s s lead development program, vidofludimus calcium (IMU-838), is in phase III and phase II clinical trials for the treatment of relapsing and progressive multiple sclerosis, respectively, and has shown therapeutic activity in phase II clinical trials in patients suffering from relapsing-remitting multiple sclerosis, progressive multiple sclerosis, and moderate-to-severe ulcerative colitis. We show 31 historical shares outstanding datapoints in our coverage of IMUX's shares outstanding history. Understanding the changing numbers of IMUX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like IMUX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching IMUX by allowing them to research IMUX shares outstanding history as well as any other stock in our coverage universe. |
| IMUX Current Stock Quote |
Quotes delayed 20 minutes  Free IMUX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| IMUX Share Performance |
| Shares Outstanding Peers |
| Immunic (IMUX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
IMV Shares Outstanding History IMVT Shares Outstanding History INAB Shares Outstanding History INBS Shares Outstanding History INBX Shares Outstanding History INCY Shares Outstanding History INDP Shares Outstanding History INDV Shares Outstanding History INFI Shares Outstanding History INGN Shares Outstanding History More Healthcare companies » |
IMUX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
